Cargando…
B cell repertoires in HLA-sensitized kidney transplant candidates undergoing desensitization therapy
BACKGROUND: Kidney transplantation is the most effective treatment for end-stage renal disease. Sensitization refers to pre-existing antibodies against human leukocyte antigen (HLA) protein and remains a major barrier to successful transplantation. Despite implementation of desensitization strategie...
Autores principales: | Beausang, John F., Fan, H. Christina, Sit, Rene, Hutchins, Maria U., Jirage, Kshama, Curtis, Rachael, Hutchins, Edward, Quake, Stephen R., Yabu, Julie M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5237299/ https://www.ncbi.nlm.nih.gov/pubmed/28086979 http://dx.doi.org/10.1186/s12967-017-1118-7 |
Ejemplares similares
-
Immune Profiles to Predict Response to Desensitization Therapy in Highly HLA-Sensitized Kidney Transplant Candidates
por: Yabu, Julie M., et al.
Publicado: (2016) -
Tocilizumab Trough Levels Variability in Kidney-Transplant Candidates Undergoing Desensitization
por: Truffot, Aurélie, et al.
Publicado: (2021) -
The promise and challenge of high-throughput sequencing of the antibody repertoire
por: Georgiou, George, et al.
Publicado: (2014) -
The Repertoires of Ubiquitinating and Deubiquitinating Enzymes in Eukaryotic Genomes
por: Hutchins, Andrew Paul, et al.
Publicado: (2013) -
Prime Time for HLA Desensitization: Imlifidase in the Spotlight
por: Bestard, Oriol, et al.
Publicado: (2023)